Apoptotic effects of Lycopodium clavatum extract on SKBR-3 human breast cancer cells
Abstract
Keywords
Lycopodium clavatum extract , SKBR-3 , human breast cancer , cytotoxicity , apoptosis
Kaynakça
- Azamjah N, Soltan-Zadeh Y, Zayeri F. Global trend of breast cancer mortality rate: a 25-year study. Asian Pac J Cancer Prev. 2019;20:2015-2020.
- Naeem M, Iqbal MO, Khan H, Ahmed MM, Farooq M, Aadil MM, et al. A review of twenty years of research on the regulation of signaling pathways by natural products in breast cancer. Molecules. 2022;27:3412.
- Das S, Das J, Samadder A, Boujedaini N, Khuda-Bukhsh AR. Apigenin-induced apoptosis in A375 and A549 cells through selective action and dysfunction of mitochondria. Exp Biol Med. 2012;237:1433-48.
- Banerjee JN, Biswas S, Madhu NR, Karmakar SR, Biswas SJ. A better understanding of pharmacological activities and uses of phytochemicals of Lycopodium clavatum: A review. J Pharmacogn Phytochem. 2014;3:207-10.
- Mandal SK, Biswas R, Bhattacharyya SS, Paul S, Dutta S, Pathak S, et al. Lycopodine from Lycopodium clavatum extract inhibits proliferation of HeLa cells through induction of apoptosis via caspase-3 activation. Eur J Pharmacol. 2010;626:115-22.
- Banerjee A, Pathak S, Jothimani G, Roy S. Antiproliferative effects of combinational therapy of Lycopodium clavatum and quercetin in colon cancer cells. J Basic Clin Physiol Pharmacol. 2020;31:1-12.
- Samadder A, Das S, Das J, Paul A, Boujedaini N, Khuda-Bukhsh AR. The potentized homeopathic drug, lycopodium clavatum (5C and 15C) has anti-cancer effect on HeLa cells in vitro. J Acupunct Meridian Stud. 2013;6:180-7.
- Mu S, Liu Z, Duan M, Yan Y, Liu G, Liu S et al. Transdermal permeation research of ethanol extracts from Lycopodium clavatum. IOP Conf Ser: Earth Environ Sci. 2020;559:012026.
- Goswami HK, Sen K, Mukhopadhyay R. Pteridophytes: evolutionary boon as medicinal plants. Plant Genet Resour. 2016;14:328-55.
- Bishayee K, Chakraborty D, Ghosh S, Boujedaini N, Khuda-Bukhsh AR. Lycopodine triggers apoptosis by modulating 5-lipoxygenase, and depolarizing mitochondrial membrane potential in androgen sensitive and refractory prostate cancer cells without modulating p53 activity: signaling cascade and drug-DNA interaction. Eur J Pharmacol. 2013;698:110-21.
